Medicina

2022

1. Alveolar rhabdomyosarcoma with cannibalism and erythroid leukaemia-like morphology

   International Journal of Laboratory Hematology

2. Author Correction: Machine learning-based model for prediction of clinical deterioration in hospitalized patients by COVID 19 (Scientific Reports, (2022), 12, 1, (7097), 10.1038/s41598-022-09771-z)

   Scientific Reports

3. Bacteremic pneumococcal pneumonia: arrhythmogenic disease

   Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia

4. Correction to: Real-world Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis patients in Spain: Results of a multicenter, observational study in routine clinical practice (The ORBIT-RA Study) (Rheumatology and Therapy, (2022), 9, 2, (589-608), 10.1007/s40744-021-00423-8)

   Rheumatology and Therapy

5. Correction to: Surgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry (Infection, (2022), 50, 5, (1191-1202), 10.1007/s15010-022-01792-0)

   Infection

6. Corrigendum to “Prognosis of unexpected positive intraoperative cultures in arthroplasty revision: A large multicenter cohort” [Journal of Infection 83 (2021) 542–549] (Journal of Infection (2021) 83(5) (542–549), (S0163445321004527), (10.1016/j.jinf.2021.09.001))

   Journal of Infection

7. Corrigendum to: Re-induction With Intravenous Ustekinumab in Patients With Crohn's Disease and a Loss of Response to This Therapy

   Inflammatory bowel diseases

8. Cutaneous adverse events with febuxostat after previous reactions to allopurinol: comment on the article by Singh and Cleveland

   Annals of the Rheumatic Diseases

9. Emotional and psychological impact of infection and postCOVID-19 in older people: beyond the usual symptoms of long COVID

   European Geriatric Medicine

10. Erratum: Re-induction with Intravenous Ustekinumab in Patients with Crohn's Disease and a Loss of Response to This Therapy (Inflammatory Bowel Diseases DOI: 10.1093/ibd/izab015)

    Inflammatory Bowel Diseases

11. Erratum: TEMPORARY REMOVAL: PO-14: Real-world data: incidence of venous thromboembolism recurrence and bleeding among cancer patients (Thrombosis research PII: S0049-3848(22)00202-X)

    Thrombosis research

12. Erratum: TEMPORARY REMOVAL: PO-55: Effectiveness and safety of enoxaparin in the extended treatment of venous thromboembolism in active cancer patients with renal impairment: results from the RIETECAT-RI cohort study (Thrombosis research PII: S0049-3848(22)00245-6)

    Thrombosis research

13. Fibromyalgia: Adversity from the healthcare system

    Atencion Primaria

14. Hairy kidney in high-grade B-cell lymphoma

    International Journal of Hematology

15. Humoral Response to Third Dose of SARS-CoV-2 Vaccines in the CKD Spectrum

    Clinical journal of the American Society of Nephrology : CJASN

16. Hyper-Reflective Outer Nuclear Layer (HONL) in Vogt–Koyanagi–Harada Disease and Sympathetic Ophthalmia

    Ocular Immunology and Inflammation

17. Independent clinical research: hobby or profession

    Gastroenterologia y Hepatologia

18. Intracytoplasmic crystalline inclusions in peripheral blood lymphocytes in small lymphocytic lymphoma

    British Journal of Haematology

19. Multidisciplinary Consensus for the Management of Pulmonary Thromboembolism

    Archivos de Bronconeumologia

20. The hazard of combining anticoagulants with antiplatelets in patients with venous thromboembolism: Findings from the RIETE registry

    Thrombosis Research